Various p53 mutant types differently regulate the Ras circuit to induce a cancer-related gene signature
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Concomitant expression of mutant p53 and oncogenic Ras, leading to cellular transformation, is well documented. However, the mechanisms by which the various mutant p53 categories cooperate with Ras remain largely obscure. In this study we suggest that different mutant p53 categories cooperate with H-Ras in different manners to induce a unique expression pattern of a cancer related gene signature (CGS). The DNA-contact p53 mutants (p53R248Q and p53R273H) exhibited the highest level of CGS expression by cooperating with NFκB. Furthermore, the Zn+2 region conformational p53 mutants (p53R175H and p53H179R) induced the CGS by elevating H-Ras activity. This elevation in H-Ras activity stemmed from a perturbed function of the p53 transcription target gene, BTG2. In contrast, the L3 loop region conformational mutant (p53G245S) did not affect the CGS expression. Our findings were further corroborated in human tumor-derived cell lines expressing Ras and the aforementioned mutated p53 proteins. These data might assist in future tailor-made therapy which targets the mutant p53-Ras axis in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Genes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922 · cited 7×
“As expected, the L3 loop region conformational mutant (p53G245S) that does not affect HRas activity also did not interact with BTG2 (Fig.”
BackgroundInfluentialCrystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,551 · cited 2×
“The second group includes p53 conformational mutations (e.g. R175, H179), which alter the scaffold that orients the structure of the DNA-binding interface (Cho et al., 1994).”
BackgroundRAS oncogenes: the first 30 years
Malumbres, M., & Barbacid, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1097 · Cited by 1,902 · cited 1×
“Ras activation depends on its binding to GDP (the nonactive state) or GTP, which enables its active conformation (Malumbres and Barbacid, 2003).”
BackgroundWhen mutants gain new powers: News from the mutant p53 field
Brosh, R., & Rotter, V. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2693 · Cited by 1,132 · cited 1×
“When mutated, p53 either acts in a dominant-negative manner, in which it inhibits wild-type p53 tumor-suppressive functions, or acts in a gain-of-function manner, in which mutant p53 shows additional oncogenic activities, supporting tumorigenesis (Brosh and Rotter, 2009).”
BackgroundSelf-citationBuganim, Y., Solomon, H., Rais, Y., Kistner, D., Nachmany, I., Brait, M., Madar, S., Goldstein, I., Kalo, E., Adam, N., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2661 · Cited by 77
Self-citation
Cited by
Muller, P. A. J., & Vousden, K. H. (2013) · Nature Cell Biology · doi:10.1038/ncb2641 · Cited by 1,647
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Muller, P. A. J., & Vousden, K. H. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.021 · Cited by 1,545
“Data from cell lines suggest that conformational and contact mutants can cooperate via different mechanismswith theH-Ras signaling pathway, leading to similar gene expression profiles and tumorigenesis (Solomon et al., 2012).”
Backgroundp53 signaling in cancer progression and therapy
Marei, H. E., Althani, A., Afifi, N., Hasan, A., Caceci, T., Pozzoli, G., Morrione, A., Giordano, A., & Cenciarelli, C. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02396-8 · Cited by 588
Abrams, S. L., Lertpiriyapong, K., Yang, L. V., Martelli, A. M., Cocco, L., Ratti, S., Falasca, M., Murata, R. M., Rosalen, P. L., Lombardi, P., et al. (2018) · Advances in Biological Regulation · doi:10.1016/j.jbior.2018.06.002 · Cited by 36
Metadata
- Authors
- Solomon, H., Buganim, Y., Pomeraniec, L., Beatus, T., Assia, Y., Kogan-Sakin, I., Madar, S., Goldstein, I., Brosh, R., Kalo, E., Goldfinger, N., & Rotter, V.
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 2012-01-01
- Volume
- 125
- Issue
- Pt 13
- Pages
- 3144-52
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W2017666786
- Cited by
- 65
- References
- 6
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Various p53 mutant types differently regulate the Ras circuit to induce a cancer-related gene signature. https://app.cochat.ai/papers/10.1242/jcs.099663
- The paper
- Solomon, H., Buganim, Y., Pomeraniec, L., Beatus, T., Assia, Y., Kogan-Sakin, I., Madar, S., Goldstein, I., Brosh, R., Kalo, E., Goldfinger, N., & Rotter, V. (2012). Various p53 mutant types differently regulate the Ras circuit to induce a cancer-related gene signature. Journal of Cell Science. https://doi.org/10.1242/jcs.099663
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.